PTEN PATTERSON UTI ENERGY INC Insider Trading

PTEN CEO Hendricks sold 200,000 shares at $11.64; stock now $11.59. Company posted annual -10.2% revenue decline, $-24.6M net loss in latest quarter.

William Andrew Jr Hendricks, President & CEO of Patterson UTI Energy, sold 200,000 shares (200.0K shares) on 2026-06-05 at $11.64, reducing his holdings from 2,742,474 shares to 2,542,474 shares—a -7.3% reduction in his position. The sale is contemporaneous with deteriorating company fundamentals: annual revenue declined -10.2% year-over-year, the company recorded $-24,627,000.00 in net loss for the latest quarter, and remains unprofitable on a full-year basis with a $4.4B market cap. His prior SAME-TICKER HISTORY shows 2 prior sales at this ticker with a 0% well-timed rate (neither preceded subsequent declines), and his most recent sale at PTEN on 2026-05-01 saw the stock gain 0.4% over 90 days, indicating a pattern of sell decisions that do not precede price deterioration. The sale occurs with the stock near the lower end of its 52-week range ($5.10–$13.08), trading 11.4% below the 52-week high, while maintaining an 18.0% 90-day gain. This combination—a CEO sell during corporate underperformance and unprofitability, alongside no demonstrated timing skill in prior similar decisions at this ticker—merits investor attention to the underlying operational trajectory.

Patterson UTI COO sells 150,000 shares at $11.47; holdings drop to 421.5K (-26.2%)

James Michael Holcomb, EVP & Chief Operating Officer, sold 150,000 shares (150.0K shares) at $11.47 on 2026-05-28, reducing his post-transaction holdings to 421,523 shares (421.5K shares), a -26.2% reduction in his stake. The sale occurs against a backdrop of deteriorating company fundamentals: Patterson UTI reported a net loss of $-24,627,000.00 ($-24.6M) in its most recent full fiscal year, annual revenue declined -10.2% year-over-year, and the stock is currently -11.8% below its 52-week high. The substantial reduction in the COO's personal position, combined with the company's unprofitable state and negative revenue trajectory, warrants investor attention to near-term operational and strategic developments.

PTEN CEO sells $2.96M in shares as stock recovers from lows; company posts losses.

William Andrew Hendricks Jr., Patterson UTI Energy's President and CEO, executed a substantial sale of roughly a quarter-million shares worth nearly $3M, reducing his stake by over 8%. The timing is notable: the stock has recovered sharply from its lows and is now trading modestly below its recent highs, making this a disciplined take-profit rather than a panic exit. However, the move occurs against a backdrop of fundamental headwinds—the company is unprofitable with declining annual revenue and continued quarterly losses—which raises the question of whether the CEO sees limited upside at current valuations or is simply rebalancing after the recent bounce. The sale itself isn't necessarily bearish (insiders have every right to diversify), but paired with deteriorating earnings and a stock price that's rebounded significantly, it suggests caution at these levels rather than conviction in a turnaround.

Director Drummond sells 384k shares for $4.6M; stock up 20% in 30 days but company unprofitable with negative earnings.

Director Robert Wayne Drummond Jr. sold approximately 384,000 shares across two transactions in May, raising $4.6 million. This is notable because the stock has climbed significantly over the past month, yet Drummond chose to sell into that strength despite the company reporting negative earnings in both recent quarters. His own track record at this ticker is mixed: three of his four prior sales at Patterson UTI were well-timed, with the stock falling afterward, but one was poorly timed as shares rose. The company's fundamentals remain challenged—recent quarterly results show continued losses and revenue declining year-over-year—which may explain why Drummond is reducing exposure even as the stock price has recovered. This is a repeat seller; these are his 12th and 13th open-market sales in the past three years, suggesting a consistent pattern of trimming rather than accumulation.

Director Drummond Robert Wayne Jr sells entire 164,775 shares at $10.18; complete position exit amid 86.1% 90-day rally.

Director Drummond Robert Wayne Jr liquidated his entire position in PATTERSON UTI ENERGY INC—164,775 shares worth $1,677,409.50—on 2026-03-16 at $10.18, leaving zero shares post-transaction. The sale occurred as PTEN stock rose sharply, with 90-day and 30-day returns of +86.1% and +32.6% respectively; current price of $10.74 marks a new 52-week high. His same-ticker sell history at PTEN shows 2 of 2 prior measurable 90-day outcomes were well-timed (negative returns after sale dates), suggesting a pattern of exiting before declines. Conversely, his cross-ticker track record reveals a 100% well-timed sell rate across 9 prior sales with an average 90-day return of -14.4%, indicating this director has consistently sold before downturns across holdings. The company fundamentals remain pressured: negative full-year net income of $-36,402,000.00, annual revenue contraction of -10.2%, and a low P/E of 5.54 despite the recent rally, warranting scrutiny of whether this complete liquidation signals cautious positioning ahead.

Director Drummond sells 400,000 PTEN shares at $8.17; track record shows 100% well-timed sell rate at this ticker

Director Robert Wayne Drummond Jr. sold 400,000 shares of Patterson UTI Energy at $8.17 on 2026-02-13, reducing his holdings by 70.8% (from 564,775 to 164,775 shares) and generating $3,268,000.00 in proceeds. His prior trades at PTEN show a consistent pattern: two measurable prior sales at this ticker were both well-timed at the 90-day mark, with cumulative post-sale declines of 31.2% and 21.0% respectively. The current price of $7.92 is already 12.9% below the 52-week high of $9.09, and the company reported negative net income of $36,402,000.00 for the latest quarter with annual revenue declining 10.2% year-over-year. The substantial reduction in his position coincides with a company experiencing revenue contraction and operating losses, and occurs at a price that has gained 10.8% over the prior 30 days.

Director sells 718,254 shares for $4.2M at $5.87, reducing holdings 77.6%; prior sells at same ticker both well-timed.

Stewart James Carl, a director at Patterson UTI Energy, filed two separate sales on 2025-12-17 and 2025-12-18 totaling 718,254 shares for $4,216,150.98 at a blended average price of $5.87, reducing his holdings from 925,254 shares to 207,000 shares—a 77.6% reduction. This follows a strong pattern: across his prior trades at PTEN, 2 of 2 prior sells were well-timed at the 90-day mark, with 90-day returns of -23.7% and -24.9% respectively, meaning the stock declined after each sale. The company's fundamentals show revenue of $1,175,954,000.00 and net income of $-36,402,000.00, indicating unprofitability over the most recent full fiscal year despite annual revenue growth of +29.7%. The current price of $5.83 is -38.3% from the 52-week high of $9.45, placing the transaction near the lower end of recent trading range. The consistency of his prior well-timed exits at this ticker, combined with the substantial stake reduction and deteriorating profitability despite revenue growth, warrants attention to whether the sale reflects evolving conviction about near-term prospects.

PTEN CEO William Andrew Hendricks Jr. bought 25,000 shares at $7.88 on 2025-03-12, adding to 2.48M share holdings

Hendricks purchased 25,000 shares at $7.88, a disciplined addition to an already substantial 2.48M share position. The purchase occurred when PTEN traded well below its 52-week high of $12.52, with the stock down 39.2% from peak and off 17.6% over the preceding 30 days, creating a lower entry point. However, the broader context tempers interpretation: PTEN was unprofitable in its most recent full fiscal year with net income of $-978.8M against $1.4B in quarterly revenue, and the stock has continued declining since the transaction to $7.61 (current price), down an additional 3.4% from the $7.88 purchase price. While Hendricks' prior sell transactions at PTEN showed strong 90-day timing (2 of 2 were well-timed at the 90-day mark), this buy occurs amid deteriorating fundamentals and momentum, making it difficult to characterize as a clear signal of conviction versus routine portfolio management by a long-tenured CEO maintaining a large stake.

Director James Carl Stewart sells 240,149 shares ($1.8M) at $7.41 avg; retains 1,005,254 shares as PTEN stock down 37.7% from 52-week high.

STEWART JAMES CARL sold 240,149 shares across two separate transactions on 2025-03-07 for $1,779,985.58 total at a blended average price of $7.41, reducing his holdings by -19.3% to 1,005,254 shares. The sale occurred when PTEN's stock is down 37.7% from its 52-week high of $12.52 and has declined 9.5% over the prior 30 days. Despite the company reporting $1,357,222,000 in recent quarterly revenue with +29.7% year-over-year growth, it posted a net loss of $-978,761,000 and was unprofitable over the most recent full fiscal year, creating a disconnect between top-line growth and profitability. The size and timing of this divestiture warrant monitoring given the company's current loss position and the steep drawdown from peak valuation.

Director Drummond Robert Wayne Jr sold 230,000 shares of PTEN at $8.89 on 2025-02-14 (total $2.0M); retains 1.55M shares post-trade.

Drummond sold 230,000 shares representing a 12.9% reduction of his 1.78M pre-transaction position at $8.89, which is below the current price of $9.09 but well below the 52-week high of $12.52. His cross-ticker track record shows sells have been well-timed 100% of the time with an average 90-day return of -10.8%, meaning prior sales preceded stock declines. At PTEN specifically, his timing pattern is equally strong: all 3 prior sales (May 2024, March 2024, February 2024) were well-timed at the 90-day mark, with the most recent May 2024 sale preceded a -21.0% decline and earlier sales preceded -10.0% declines. However, PTEN's fundamentals present material headwinds—the company posted a net loss of $-978.8M on $1.4B quarterly revenue, reflecting unprofitability in the most recent full fiscal year, even as annual revenue growth stands at +29.7%. The pattern of consistent, well-timed exits from this position by a director, combined with deteriorating profitability despite revenue growth, suggests the insider may be positioning ahead of near-term weakness.